BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: Novel mutations and unclassified variants

Gynecologic Oncology

Volumn 125, Issue 3, 2012, Pages 687-692

  Tazzite, Amal ^a   Jouhadi, Hassan ^b   Nadifi, Sellama ^a   Aretini, Paolo ^c   Falaschi, Elisabetta ^c   Collavoli, Anita ^c   Benider, Abdellatif ^b   Caligo, Maria Adelaide ^c  

^a School of Dentistry of Casablanca   (Morocco)

^b IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

BRCA1; BRCA2; Breast cancer; Germline mutations; Morocco

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; BREAST CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; EXON; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; INTRON; MISSENSE MUTATION; MOROCCO; MUTATIONAL ANALYSIS; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; BASE SEQUENCE; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY HEALTH; FEMALE; GENE DELETION; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; INTRONS; MALE; MOLECULAR SEQUENCE DATA; MOROCCO; OVARIAN NEOPLASMS; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 84861182201     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.03.007     Document Type: Conference Paper

References (38)

1. K. Yoshida, and Y. Miki Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage Cancer Sci 95 2004 866 871
2. Y. Miki, J. Swensen, D. Shattuck-Eidens, A. Futreal, K. Harshman, and S. Tavtigian A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
3. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, and J. Mangion Identification of the breast cancer gene BRCA2 Nature 378 1995 789 791
4. S.V. Tavtigian, J. Simard, J. Rommens, F. Couch, D. Shattuck-Eidens, and S. Neuhausen The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds Nat Genet 12 1996 333 337
5. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 Penetrance J Clin Oncol 25 2007 1329 1333
6. R. Ferla, V. Calo, S. Cascio, G. Rinaldi, G. Badalamenti, and I. Carreca Founder mutations in BRCA1 and BRCA2 genes Ann Oncol 18 2007 93 98
7. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
8. A. Benider, M. Bennani Othmani, M. Harif, M. Karkouri, A. Quessar, and S. Sahraoui Registre des cancers de la région du Grand Casablanca, Année 2004 2007
9. M.A. Tazi, N. Benjaafar, and A. Er-Raki Registre des Cancers de Rabat. Incidence des Cancers à Rabat, Année 2005 2009
10. M. Hamdi Cherif, Z. Zaidi, D. Abdellouche, S. Hamdi, N. Lakhdari, and A. Djema Bendjazia Registre du cancer de Sétif (Algérie): incidence, tendance et survie, 1986-2005 J Afr Cancer 2 2010 245 258
11. M. Ben Abdallah, S. Zehani, M. Maalej, M. Hsairi, M. Hechiche, and K. Ben Romdhane Cancer du sein en Tunisie: caractéristiques épidémiologiques et tendance évolutive de l'incidence Tunis Med 87 2009 417 425
12. M. El Mistiri, M. Pirani, N. El Sahli, M. El Mangoush, A. Attia, and R. Shembesh Cancer profile in eastern Libya: incidence and mortality in the year 2004 Ann Oncol 21 2010 1924 1926
13. L.D. Marrett, P. De, P. Airia, and D. Dryer Cancer in Canada in 2008 CMAJ 179 2008 1163 1170
14. J.L. Botha, F. Bray, R. Sankila, and D.M. Parkin Breast cancer incidence and mortality trends in 16 European countries Eur J Cancer 39 2003 1718 1729
15. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
16. L.L. Cavalli-Sforza, P. Menozzi, and A. Piazza The history and geography of human genes 1994 Princeton University Press Princeton, NJ
17. P.C. Ng, and S. Henikoff SIFT: predicting amino acid changes that affect protein function Nucleic Acids Res 31 2003 3812 3814
18. V. Ramensky, P. Bork, and S. Sunyaev Human non-synonymous SNPs: server and survey Nucleic Acids Res 30 2002 3894 3900
19. S.V. Tavtigian, A.M. Deffenbaugh, L. Yin, T. Judkins, T. Scholl, and P.B. Samollow Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral J Med Genet 43 2006 295 305
20. C. Béroud, G. Collod-Beroud, C. Boileau, T. Soussi, and C. Junien UMD (universal mutation database): a generic software to build and analyze locus-specific databases Hum Mutat 15 2000 86 94
21. C. Béroud, D. Hamroun, G. Collod-Beroud, C. Boileau, T. Soussi, and M. Claustres UMD (universal mutation database): 2005 update Hum Mutat 26 2005 184 191
22. F.O. Desmet, D. Hamroun, M. Lalande, G. Collod-Beroud, M. Claustres, and C. Beroud Human splicing finder: an online bioinformatics tool to predict splicing signals Nucleic Acids Res 37 2009 e67
23. W. Troudi, N. Uhrhammer, C. Sibille, C. Dahan, W. Mahfoudh, and C. Bouchlaka Souissi Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia J Hum Genet 52 2007 915 920
24. F. Cherbal, R. Bakoura, S. Adaneb, K. Boualgac, G. Benais-Pont, and P. Maillet BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families Dis Markers 28 2010 377 384
25. J.D. Fackenthal, and O.I. Olopade Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations Nat Rev Cancer 7 2007 937 948
26. N. Uhrhammer, A. Abdelouahab, L. Lafarge, V. Feillel, A. Ben Dib, and Y.J. Bignon BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases Int J Med Sci 5 2008 197 202
27. W. Mahfoudh, N. Bouaouina, S. Ben Ahmed, S. Gabbouj, J. Shan, and R. Mathew Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population Mol Biol Rep 2011 10.1007/s11033-011-0829-8 First published on May 21, 2011
28. E.M. John, A. Miron, G. Gong, A.I. Phipps, A. Felberg, and F.P. Li Prevalence of pathogenic BRCA1 mutation carriers in 5 U.S. racial/ethnic groups JAMA 298 2007 2869 2876
29. F. Baudi, F. Fabiani, E. Leone, B. Quaresima, I. Cucinotto, and M. Ventura Ten years of BRCA testing in calabrian population Ann Oncol 20 2009 89 106
30. P.S. Brzovic, J. Meza, M.C. King, and R.E. Klevit The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain J Biol Chem 273 1998 7795 7799
31. P.S. Brzovic, J.E. Meza, M.-C. King, and R.E. Klevit BRCA1 Ring domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions J Biol Chem 44 2001 41399 41406
32. R. Janavičius Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control EPMA J 1 2010 397 412
33. J. Vallon-Christersson, C. Cayanan, K. Haraldsson, N. Loman, J.T. Bergthorsson, and K. Brondum-Nielsen Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families Hum Mol Genet 10 2001 353 360
34. D.F. Easton, A.M. Deffenbaugh, D. Pruss, C. Frye, R.J. Wenstrup, and K. Allen-Brady A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer- predisposition genes Am J Hum Genet 81 2007 873 883
35. S. Malacrida, S. Agata, M. Callegaro, C. Casella, D. Barana, and M.C. Scaini BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy J Clin Oncol 26 2008 26 31
36. A. De Nicolo, E. Parisini, Q. Zhong, M. Dalla Palma, K.A. Stoeckert, and S.M. Domchek Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del Cancer Res 69 2009 7030 7037
37. M.K. Shivji, and A.R. Venkitaraman DNA recombination, chromosomal stability and carcinogenesis: insights into the role of BRCA2 DNA Repair (Amst) 3 2004 835 843
38. M.A. Unger, K.L. Nathanson, K. Calzone, D. Antin-Ozerkis, H.A. Shih, and A.M. Martin Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by confirmation-sensitive gel electrophoresis or sequencing Am J Hum Genet 67 2000 841 850